| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aptevo Therapeutics Inc (NASDAQ: APVO)
APVO Technical Analysis
5
| As on 9th Jun 2023 APVO STOCK Price closed @ 1.56 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.58 & Strong Sell for SHORT-TERM with Stoploss of 6.38 we also expect STOCK to react on Following IMPORTANT LEVELS. |
APVOSTOCK Price
| Open | 1.59 | Change | Price | % |
| High | 1.63 | 1 Day | -0.05 | -3.11 |
| Low | 1.53 | 1 Week | 0.00 | 0.00 |
| Close | 1.56 | 1 Month | -0.41 | -20.81 |
| Volume | 58300 | 1 Year | -6.43 | -80.48 |
| 52 Week High 8.42 | 52 Week Low 1.56 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| APVO Daily Charts |
APVO Intraday Charts |
Whats New @ Bazaartrend |
APVO Free Analysis |
|
|
APVO Important Levels Intraday
| RESISTANCE | 1.75 |
| RESISTANCE | 1.69 |
| RESISTANCE | 1.65 |
| RESISTANCE | 1.61 |
| SUPPORT | 1.51 |
| SUPPORT | 1.47 |
| SUPPORT | 1.43 |
| SUPPORT | 1.37 |
APVO Forecast April 2024
| 4th UP Forecast | 7.15 |
| 3rd UP Forecast | 5.36 |
| 2nd UP Forecast | 4.25 |
| 1st UP Forecast | 3.14 |
| 1st DOWN Forecast | -0.02 |
| 2nd DOWN Forecast | -1.13 |
| 3rd DOWN Forecast | -2.24 |
| 4th DOWN Forecast | -4.03 |
APVO Weekly Forecast
| 4th UP Forecast | 3.97 |
| 3rd UP Forecast | 3.20 |
| 2nd UP Forecast | 2.72 |
| 1st UP Forecast | 2.24 |
| 1st DOWN Forecast | 0.88 |
| 2nd DOWN Forecast | 0.40 |
| 3rd DOWN Forecast | -0.08 |
| 4th DOWN Forecast | -0.85 |
APVO Forecast2024
| 4th UP Forecast | 15.13 |
| 3rd UP Forecast | 10.78 |
| 2nd UP Forecast | 8.09 |
| 1st UP Forecast | 5.4 |
| 1st DOWN Forecast | -2.28 |
| 2nd DOWN Forecast | -4.97 |
| 3rd DOWN Forecast | -7.66 |
| 4th DOWN Forecast | -12.01 |
Aptevo Therapeutics Inc ( NASDAQ USA Symbol : APVO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
APVO Business Profile
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1/1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers; and APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40. It is also developing APVO442, a bispecific candidate based on the ADAPTIR-FLEX platform technology to enhance biodistribution of drugs to PSMA positive tumors for treatment of prostate cancer; and other pre-clinical development stage therapeutics focused on hematologic and solid tumors. It has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington. Address: 2401 4th Avenue, Seattle, WA, United States, 98121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service